CORC

在结果中检索

CORC

浏览/检索结果: 共38条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
RATIONALE 001: Tislelizumab (BGB-A317) 1 concurrent chemoradiotherapy (cCRT) followed by tislelizumab monotherapy in patients (pts) with newly diagnosed locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC) 会议论文
ANNALS OF ONCOLOGY, 2019-04-01
作者:  Paz-Ares, L.;  Senan, S.;  Planchard, D.;  Wang, L.;  Cheong, A.
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Primary results from TAIL, a global single-arm safety study of atezolizumab (atezo) monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer (NSCLC) 会议论文
44th Congress of the European-Society-for-Medical-Oncology (ESMO), SEP 27-OCT 01, 2019
作者:  Ardizzoni, A.;  Azevedo, S.;  Rubio Viquiera, B.;  Rodriguez Abreu, D.;  Alatorre-Alexander, J.
收藏  |  浏览/下载：16/0  |  提交时间：2019/12/31
The efficacy of anlotinib in squamous cell carcinoma (SCC) patients with or without hypertension in ALTER0303: Anlotinib as a third-line therapy in patients with advanced non-small cell lung cancer (NSCLC). 会议论文
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2019
作者:  Shi, Jianhua;  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhang, Li
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/31
Mutation status and targeted therapeutic efficacy of advanced non-small cell lung cancer: A real-world study of NSCLC in China (preCAPTRA-LUNG) 会议论文
作者:  Liang, H.;  Song, X.;  Zhang, Y.;  Zhang, S.;  Li, F.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
A Multicenter Survey of One Year Survival Among Chinese Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506) 会议论文
作者:  Yu, P.;  Zhou, Q.;  Song, Y.;  Zhang, X.;  Chen, G.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study 会议论文
作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
CheckMate 078: Patient-Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non-Small Cell Lung Cancer (NSCLC) 会议论文
作者:  Wu, Y.;  Chang, J.;  Zhang, L.;  Tu, H.;  Wu, L.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
AURA17 study of osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC): Updated phase II results including overall survival (OS) 会议论文
ANNALS OF ONCOLOGY, 2018-11-01
作者:  Zhou, C.;  Wang, M.;  Cheng, Y.;  Chen, Y.;  Zhao, Y.
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Mutation status and targeted therapeutic efficacy of advanced non-small cell lung cancer: A real-world study of NSCLC in China (preCAPTRA-LUNG) 会议论文
ANNALS OF ONCOLOGY, 2018-11-01
作者:  Liang, H.;  Song, X.;  Zhang, Y.;  Zhang, S.;  Li, F.
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03
Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study 会议论文
CANCER RESEARCH, 2018-07-01
作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace